Center For AIDS Research

April 21-28, 2015

The Network News
April 21-28, 2015
Divider Rule Numbers of the Year ...
$40,000,000:     Minimum annual amount of "allowable"* NIH AIDS funding that Emory University needs to receive each year during both FY2015 and FY2016 in order to qualify for requesting an increase to "Tier II" funding at our next competitive renewal
So how have we been doing towards that goal?
$37,903,769:     FY12 allowable* funding total
$39,697,253:     FY13 allowable* funding total
$50,277,124:     FY14 allowable* funding total

Watch the CFAR Leadership react to the news

*NIH includes only specified mechanisms and grants in the "allowable" total

Divider Rule Kudos ...

... to the 51 PIs whose 75 awards appearing on the FY14 NIH CFAR "Allow" Tab, totaled $50,277,124 in funding for Fiscal Year 2014; the highest in CFAR's history:

Susan Allen, Rama Amara, Bert Anderson, Deborah Anderson, Aftab Ansari, Hank Blumberg, Jeremy Boss, Siddappa Byrareddy, Hannah Cooper, Cheryl Day, Cindy Derdeyn, Ralph Diclemente, Allison Eckard, Brian Evavold, Neel Gandhi, Neela Goswami, Arash Grakoui, David Guidot, Lisa Haddad, Marcia Holstad, Eric Hunter, Ameeta Kalokhe, Colleen Kelley, Baek Kim, Geoff Lennox, Bill Lewis, Dennis Liotta, Greg Melikian, Igho Ofotokun, Mirko Paiardini, Bali Pulendran, Arshed Quyyumi, Jyothi Rengarajan, Nabil Saba, Ray Schinazi, Anandi Sheth, Guido Silvestri, Anne Spaulding, Paul Spearman, Sam Speck, Rob Stephenson, Patrick Sullivan, Mehul Suthar, Roy Sutliff, Francois Villinger, Drenna Waldrop-Valverde, Ifor Williams, Mark Wilson, Frank Wong, Chinglai Yang, and Benjamin Youngblood

...and to 9 PIs whose NIH awards, even though they do not count towards the CFAR's funded research base, collectively brought $13,049,042 in more NIH AIDS funding to Emory in FY2014:

Stewart Caughman, Jim Curran, Danielle Haley, Dean Jones, Meridith Mikulich, Emily
, David Stephens, Joshua Strauss, and Aaron Vissman



in NIH AIDS funding during FY2014

The Highest in Emory's History

Yay Team CFAR!!

(now all you have to do is keep it up for 2 more years!)
(FY2015 and FY2016)

Divider Rule In other news...

Happy Birthday

... to Stuart Zola (April 23), Danny Branstetter (April 26), and Chinglai Yang (April 28)

True friends remember your birthday, but not your age – count us among your true friends

Our exhuberance above makes it sound like NIH is the only funder who supports Emory HIV/AIDS researchers. Au Contraire! Check this duo out...

     Ann Spaulding

Here's a problem ... the prevalence of HIV among inmates can be more than 3x higher than in the general public (yeah, gasp!) -- so how do you ensure that inmates don't take a dive off the continuum of care after they leave the joint? Enter the Professor and the Pop Star. Anne Spaulding has recently been awarded a second round of funding from the Elton John Foundation to link inmates with HIV to care before they leave the correctional system.
Read the original article about it from her first round of funding

Andres Camacho Gonzalez     

Inmates aren't the only ones who tend to wipe out when surfing the cascade of care ... It turns out that adolescents with HIV aren't any more compliant in following adult advice than your standard issue teenager is, which can be bad news for retention and treatment. Andres Camacho-Gonzalez has an app for that! Andres recently received funding from the Georgia Department of Health for HealthySteps: Improving HIV Treatment Compliance One Step at a Time, a mobile phone app that is specifically designed to increase linkage to care, retention in care, and medication adherence in HIV-infected adolescents and young adults who have a history of poor treatment compliance.

Divider Rule Bulletin Board...

bulletin board

HIV+ Study Subjects Wanted: ACTG A5332
In the REPRIEVE (randomized trial to prevent vascular events in HIV) study, people with HIV between 40 - 75 yrs will be randomized to take the pill pitavastatin OR a placebo to see if pitavastatin can help prevent heart disease and death in people on HIV meds. The study lasts approximately 72 months (6 years) and you will not know if you are taking pitavastatin or placebo. The REPRIEVE trial is seeking to enroll 6500 people from several countries
Read the study flyer

More HIV+ Study Subjects Wanted: ACTG A5315
A5315 is a phase I/II, double-blinded, randomized, placebo-controlled, dose-escalation study to evaluate the safety and efficacy of a single dose administration of romidepsin (RMD). Three cohorts (1-3) of 15 subjects each will be sequentially enrolled into the study (depending on safety outcomes, which will determine whether to dose escalate or not). Toxicity related to the administration of RMD will be evaluated systematically.
Read the study flyer

Divider Rule Government News...

Government News

No HIV-related government news this week

Divider Rule Focus On...: New Biosketch Feedback Opportunity

Focus On...    
     NaNo Humor Writer's Block from
     From NaNo Humor

Quoted from the Department of Medicine Researchers Listserv:

"Will you be submitting an NIH grant on or after May 25, 2015?"

"Is the new NIH biosketch format giving you anxiety?"

"Would you like suggestions and direct feedback on your newly-formatted biosketch from seasoned NIH reviewers?"

"If you answered "yes" to these questions, then you should consider submitting your newly-formatted biosketch to be reviewed at the upcoming Research Resources 101 session on May 21. We will select and showcase a few biosketches during that session to seek comments and suggestions for strategic improvement from our esteemed panel of NIH reviewers. If you would like to be considered for this unique opportunity to gain collective wisdom on your newly formatted biosketch, please submit a draft in the new format to Karen Summers ( by Monday, May 7, 2015."

Divider Rule

Funding Opps


June 29 (LOI)
Sponsor: NIAID
Innovation for HIV Vaccine Discovery

September 7 (App)
Sponsor: NIDA
AIDS-Science Track Award for Research Transition
(to support research projects on drug abuse and HIV/AIDS)


See previously advertised Funding Opportunities in Network News archived issues.

top Divider Rule pubs

Recent Pubs
that link to the CFAR grant
(P30 AI050409)

Claiborne DT, Prince JL, Scully E, Macharia G, Micci L, Lawson B, Kopycinski J, Deymier MJ, Vanderford TH, Nganou-Makamdop K, Ende Z, Brooks K, Tang J, Yu T, Lakhi S, Kilembe W, Silvestri G, Douek D, Goepfert PA, Price MA, Allen SA, Paiardini M, Altfeld M, Gilmour J, Hunter E. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression.
Proc Natl Acad Sci U S A. 2015 Feb 17. pii: 201421607. [Epub ahead of print]

Lahiri CD, Tao S, Jiang Y, Sheth AN, Acosta EP, Marconi VC, Armstrong WS, Schinazi RF, Vunnava A, Sanford S, Ofotokun I. Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients.
AIDS. 2015 Apr 13. [Epub ahead of print]

Calendar Upcoming Events
April 23
ID Seminar
1) Research in Progress: Plasma Interferon-Gamma Induced Protein 10 (IP-10) for Monitoring of Treatment Response in Active Pulmonary Tuberculosis
Starring: Marcos Coutinho-Schechter, MD
   2nd Year ID Fellow
2) Defining CD4+ T Cell Immune Recovery after ART
Starring: Sol Aldrete, MD
   2nd Year ID Fellow
Location: RSPH / GCR / Rita Anne Rollins Room

April 23
6:00 - 8:00pm
Community Networking
1st Annual "Strengthen by Numbers" HIV/AIDS Community Forum
Starring: The Emory-CDC HIV/AIDS Clinical Trials Unit faculty
Location: Phillip Rush Center (1530 DeKalb Avenue NE)
• Questions: Email Marc Padilla

April 28
HOPE Webinar
Atherosclerosis and Cardiovascular Risk Reduction in HIV-infected Patients
Starring: Janet Lo, M.D.
Focus: Physicians
Sponsor: Harvard CFAR
HOPE Conference Website
To Attend Webinar: Click this link on 4/28

Calendar Farther Down the Road
April 29
HOPE Webinar
HIV Pre-Exposure Prophylaxis: Shifting the Epidemic
Starring: Jeffrey Kwong, DNP, MPH, ANP-BC
Focus: Nurses
Sponsor: Harvard CFAR
HOPE Conference Website
To Attend Webinar: Click this link on 4/29

May 17-19 (Conference)
Italian Conference on AIDS and Retroviruses
Location: Riccione, Italy

May 18-21
50th Annual USPHS Scientific and Training Symposium
Public Health Diversity: Succeeding in a Flatter World
Location: Sheraton Atlanta

October 5 (Abstract Deadline)
December 6-10 (Conference)
Frontiers in Drug Development for Viral Hepatitis
Location: Wailea, Maui, Hawaii
Abstract Submission Information

October 28-30: Save the Date
SNSRN 2015
Integrating Social, Behavioral, and Biomedical Strategies: The Future of HIV/AIDS Prevention and Care Research
Host: Johns Hopkins University CFAR
Location: Baltimore


Divider Rule
Spotlight Spotlight

Footlights | Vaccine Dinner Club - Wednesday, May 6

     VDC logo


Count Me In!
Click Here to Register

In Flew Enza:
Influenza Vaccination ...
Past, Present, and Future Challenges


Nancy Cox, PhD
Director (retired)
CDC Influenza Division


Divider Rule
CFAR logo

The Network News is a periodic email, detailing HIV/AIDS related events, funding opportunities, and achievements of CFAR members. If you have items that you wish to have included, please send them to us at by Friday of each week. Please put "The Network News" in the subject line.

The Network News is distributed to CFAR members and fans by email every Monday. Except when it isn't.

Editor, Kimberley (Kimbi) Sessions Hagen, EdD

Divider Rule
Emory University Center for AIDS Research Emory University Center for AIDS Research